United Hayek Medical announced that FDA clearance has been received for the sale of the Hayek RTX non-invasive ventilator. The Hayek RTX ventilator provides an efficient and effective method of non-invasive external ventilation that actively controls the inspiratory and expiratory phases of respiration using biphasic cuirass ventilation (BCV). This compact and lightweight ventilator is ideally suited for use in acute and chronic, intubated or non-intubated patients. BCV has been proven extremely effective in ventilating large variety patients, with supporting documentation available in over 100 publications. The Hayek RTX additionally provides secretion clearance and cough assist modes that have been shown to be more effective with greater comfort, increasing patient compliance with prescribed therapies.

United Hayek Medical specializes in the design, manufacture, and sale of non-invasive respiratory devices, which provide a real non-invasive alternative for patient ventilation. The late Dr. Zamir Hayek invented the Hayek RTX series of ventilators and was the leading pioneer in the field of cuirass ventilation. Dr. Hayek’s vision was to create a device that would provide complete ventilation, be non-invasive, work physiologically, be simple to use, and would overcome the many issues associated with existing ventilation techniques. United Hayek Medical's goal is to improve patient outcomes while providing a better quality of life for patients needing ventilatory support.

United Hayek Medical customers include hospitals, home care, emergency, military, and other healthcare providers worldwide. United Hayek Medical is a world leader in BCV ventilation and innovative medical technologies to improve the quality of life for patients. For further information, visit www. UnitedHayek.com or call 1-619-272-2333.